Search Site

Zilico Limited

Zilico News

Keep up to date with the latest news and press releases from Zilico.

  • Zilico Shortlisted for Prestigious Healthcare Award

    Sep '16 27

    Zilico has been shortlisted in the ‘Improving Care with Technology’ category at the 2016 Health Service Journal (HSJ) Awards, to be held on 23 November at Intercontinental O2, London. 
    more details ]
  • Staffordshire women offered more accurate cervical cancer diagnosis

    Sep '16 26

    Two hospitals in Staffordshire have introduced a pioneering new technology designed to improve the speed and accuracy in diagnosing pre-cancerous conditions of the cervix. The University Hospitals of North Midlands NHS Trust have adopted an innovative cervical cancer diagnostic system called ZedScan™ at the gynaecology departments at both the Royal Stoke University Hospital and County Hospital Stafford. Its aim is to offer a more accurate diagnosis for women who are at risk of cervical cancer.
    more details ]
  • Benefits of ZedScan highlighted at RCOG 2016

    Jun '16 29

    The role of ZedScan on improving clinical performance and efficient patient management was highlighted at the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress by Pierre Martin-Hirsch. 
    more details ]
  • The Changing Face of Colposcopy

    Jun '16 29

    Discussion around how the introduction of HPV primary testing, vaccination and the use of adjunctive technologies are changing the face of colposcopy was a key focus at this year’s Royal College of Obstetricians and Gynaecologists (RCOG) World Congress.
    more details ]
  • Zilico Ltd selected for the Inaugural TechEmerge Health Innovation Summit

    Jun '16 10

    Zilico Ltd has been selected to participate in the inaugural TechEmerge program, an initiative of IFC, a member of the World Bank Group. TechEmerge is a first-of-its-kind matchmaking program that connects technology companies from around the world with corporations in emerging markets, to conduct pilot projects and foster commercial partnerships. The inaugural phase of the program is focused on the healthcare sector in India.
    more details ]
  • ZedScan™ delivers significant increase in HG CIN detection rates across all high risk HPV positive women

    Apr '16 12

    A review into the management of more than 800 women referred to an NHS colposcopy clinic who were positive for high risk HPV (hrHPV) has revealed a substantial increase in detection of high grade cervical intraepithelial neoplasia (HG CIN) following the adoption of ZedScan into routine use. 
    more details ]
  • Zilico Ltd selected for the 2016 Medical Device Hotlist

    Mar '16 18

    Zilico Ltd has been selected for inclusion in the 2016 Medical Device SME Hotlist , published by the Council of European BioRegions asbl (CEBR), following a nomination by CEBR member TRUSTECH .
    more details ]
  • Professor Tidy guest lecturer at South Asian cancer conference

    Mar '16 1

    Zilico Ltd’s clinical founder, Professor John Tidy, has been invited by the Delhi State Cancer Institutes to participate in an international cancer conference in India.
    more details ]
  • 1,000 patient case study published for ZedScan™

    Jan '16 22

    Zilico Ltd has published a 1,000 patient case study for its cervical cancer diagnostic system, ZedScan ™ , to coincide with the start of Cervical Cancer Prevention Week (24-30 January).   The patient review in to the routine use of ZedScan as an adjunct to colposcopy has revealed that the technology significantly increases the rate of detection of high grade cervical intraepithelial neoplasia (HG CIN).
    more details ]
  • Zilico appoints new Commercial Director

    Jan '16 12

    Zilico Ltd has strengthened its team with the appointment of a new Commercial Director. Andrew Saipe, who has 25 years’ experience in medical sales, joins Zilico from Purple Surgical, where he looked after many of the International markets for eight years. Prior to this, Andrew was a sales manager with Medtronic (Covdien) for 5 years.
    more details ]